What question did this study set out to answer?

The response aims to address engagement concerning the guidelines for screening and managing ILD in connective tissue diseases.

April 4, 2026

Reply on behalf of the ERS/EULAR task force for connective tissue disease-associated interstitial lung disease

Key Points

The response aims to address engagement concerning the guidelines for screening and managing ILD in connective tissue diseases.
Engagement and feedback from J.R. Davidsen and colleagues regarding the guidelines.
Review of evolving evidence related to screening tools for ILD in rheumatoid arthritis.
Acknowledgment of interest in the guidelines.
Recognition of advancements in screening tools for RA-associated ILD.

Abstract

Extract We appreciate the interest and engagement from J.R. Davidsen and co-workers regarding the recently published European Respiratory Society (ERS)/European Alliance of Associations for Rheumatology (EULAR) clinical practice guidelines for connective tissue disease-associated interstitial lung disease (CTD-ILD) 1, 2. We recognise the rapidly evolving evidence landscape for screening tools in rheumatoid arthritis-associated ILD (RA-ILD).

AIに質問

Bookmark